We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow %
86.51%
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$911M
2
ADCT icon
ADC Therapeutics
ADCT
+$55.1M
3
KYNB
Kyntra Bio
KYNB
+$25.5M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$5.96M
5
KR icon
Kroger
KR
+$366K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.04%
2 Technology 0.89%
3 Consumer Discretionary 0.79%
4 Industrials 0.61%
5 Consumer Staples 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
G icon
1751
Genpact
G
$5.96B
$1K ﹤0.01%
+25
New +$988
GH icon
1752
Guardant Health
GH
$21.7B
$1K ﹤0.01%
+6
New +$690
GLOB icon
1753
Globant
GLOB
$1.58B
$1K ﹤0.01%
+6
New +$1.16K
GLPI icon
1754
Gaming and Leisure Properties
GLPI
$12.7B
$1K ﹤0.01%
+30
New +$1.21K
GOCO
1755
DELISTED
GoHealth
GOCO
$1K ﹤0.01%
+3
New +$557
GPK icon
1756
Graphic Packaging
GPK
$3.17B
$1K ﹤0.01%
+33
New +$499
GTES icon
1757
Gates Industrial Corporation Ltd.
GTES
$7.08B
$1K ﹤0.01%
+60
New +$751
GWRE icon
1758
Guidewire Software
GWRE
$12.6B
$1K ﹤0.01%
+10
New +$1.14K
H icon
1759
Hyatt Hotels
H
$16.4B
$1K ﹤0.01%
+9
New +$587
HUBS icon
1760
HubSpot
HUBS
$12.2B
$1K ﹤0.01%
+2
New +$702
INVH icon
1761
Invitation Homes
INVH
$17.7B
$1K ﹤0.01%
+40
New +$1.15K
IONS icon
1762
Ionis Pharmaceuticals
IONS
$8.6B
$1K ﹤0.01%
+17
New +$847
IOVA icon
1763
Iovance Biotherapeutics
IOVA
$1.82B
$1K ﹤0.01%
+21
New +$834
JAMF
1764
DELISTED
Jamf
JAMF
$1K ﹤0.01%
+23
New +$758
KKR icon
1765
KKR & Co
KKR
$91.1B
$1K ﹤0.01%
+21
New +$793
KNSL icon
1766
Kinsale Capital Group
KNSL
$8.12B
$1K ﹤0.01%
+7
New +$1.53K
LAZ icon
1767
Lazard
LAZ
$4.13B
$1K ﹤0.01%
+18
New +$680
LBRDA icon
1768
Liberty Broadband Class A
LBRDA
$4.89B
$1K ﹤0.01%
+8
New +$1.21K
LPLA icon
1769
LPL Financial
LPLA
$28.3B
$1K ﹤0.01%
+9
New +$809
LULU icon
1770
lululemon athletica
LULU
$13.5B
$1K ﹤0.01%
+4
New +$1.39K
LYFT icon
1771
Lyft
LYFT
$6.02B
$1K ﹤0.01%
+29
New +$1.05K
MAC icon
1772
Macerich
MAC
$7.33B
$1K ﹤0.01%
+113
New +$1.03K
MDB icon
1773
MongoDB
MDB
$27.1B
$1K ﹤0.01%
+3
New +$838
MKL icon
1774
Markel Group
MKL
$23.3B
$1K ﹤0.01%
+1
New +$997
MORN icon
1775
Morningstar
MORN
$7.22B
$1K ﹤0.01%
+3
New +$596
69 70
71
72 73

Similar funds

MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
NCM
Northwest Capital Management Lake Oswego, Oregon $23.1M AUM 13.6% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $23.7M AUM
PIM
Profit Investment Management North Bethesda, Maryland $24.7M AUM 21.29% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM
SWM
Stark Wealth Management Bethlehem, Pennsylvania $26.6M AUM 23.19% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return

Vantage Consulting Group's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.

Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.

  • Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
  • Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
  • Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.

Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.